Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Line Treatment of Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04503967
What this trial is testing

Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 48
Testing effectiveness (Phase 2)Ended earlyNCT01145404
What this trial is testing

Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer

Who this might be right for
GastroEsophageal Cancer
National Center for Tumor Diseases, Heidelberg 76
Large-scale testing (Phase 3)Ended earlyNCT01813253
What this trial is testing

Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Kuhnil Pharmaceutical Co., Ltd. 400
Early research (Phase 1)UnknownNCT03286244
What this trial is testing

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
AnewPharma 21
Large-scale testing (Phase 3)Looking for participantsNCT06203600
What this trial is testing

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+13 more
National Cancer Institute (NCI) 224
Testing effectiveness (Phase 2)UnknownNCT01573468
What this trial is testing

Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer

Who this might be right for
Gastric Carcinoma
Genta Incorporated 580
Testing effectiveness (Phase 2)Study completedNCT05025033
What this trial is testing

Chemotherapy Combined With Apatinib and PD-1 Antibody

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07031011
What this trial is testing

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

Who this might be right for
Advanced Gastric or Colorectal Cancer
jiuwei cui 22
Large-scale testing (Phase 3)Ended earlyNCT00359476
What this trial is testing

Vinflunine in Patients With Gastric Cancer

Who this might be right for
Stomach Cancer
Bristol-Myers Squibb 55
Testing effectiveness (Phase 2)Study completedNCT01956149
What this trial is testing

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 65
Testing effectiveness (Phase 2)UnknownNCT03144843
What this trial is testing

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Sun Yat-sen University 110
Testing effectiveness (Phase 2)Ended earlyNCT00816777
What this trial is testing

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colo-rectal Cancer
Generic Devices Consulting, Inc. 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339216
What this trial is testing

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03698825
What this trial is testing

TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
MedPacto, Inc. 62
Testing effectiveness (Phase 2)Ended earlyNCT00595985
What this trial is testing

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 5
Testing effectiveness (Phase 2)Study completedNCT00813072
What this trial is testing

Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
PharmaEngine 135
Testing effectiveness (Phase 2)UnknownNCT04286711
What this trial is testing

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
China Medical University, China 52
Early research (Phase 1)Study completedNCT02240212
What this trial is testing

Study of Afuresertib Combined With Paclitaxel in Gastric Cancer

Who this might be right for
Cancer
Novartis Pharmaceuticals 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701681
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ESCCGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Study completedNCT05529667
What this trial is testing

Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy.

Who this might be right for
Fibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration Gastric Cancer, INCB054828, Paclitaxel
Yonsei University 15
Next Page